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Inhibitory effects of trehalose liposomes (DMTre) composed of 30 mol % L-a-dimyristoylphosphatidyl-
choline (DMPC) and 70 mol % trehalose surfactants on the growth of lymphoblastic leukemia (MOLT-4)
cells in vitro and therapeutic effects of DMTre for xenograft mice model of carcinoma in vivo were exam-
ined. DMTre inhibited the growth of MOLT-4 cells in a dose-dependent manner due to apoptosis. The
activation of caspase-3, -8, and 9 was obtained for MOLT-4 cells after the treatment with DMTre. The
clustering of lipid rafts in plasma membranes of MOLT-4 cells was examined with a marker Cholera toxin
subunit B conjugates Alexa Fluor (CTB), which binds to the pentasaccharide chains of ganglioside GM1 on
the cellular surfaces. The clustering of lipid rafts in plasma membranes of MOLT-4 cells was observed
after the treatment with DMTre. Therapeutic effects of DMTre were obtained for xenograft mice model
of carcinoma in vivo.
 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Chemotherapy is useful therapeutic method for cancers such as
leukemia that has spread throughout the whole body. However,
most anticancer drugs affect to healthy cells in the body and lead
to side effects. Drugs without side effects are needed to attain high
quality of life for patients. Liposomes are closed vesicles that are
formed when phospholipids are dispersed in water at relatively
low concentrations.1 Liposomes have contributed significantly to
delivery, for example, antitumor agents, hormones and in
immunomodulation.2,3 Vincristine sulfate liposome injection is
for the treatment with acute lymphoblastic leukemia (ALL).4,5
However, there have been severe side effects.5 Therefore, treat-
ment method that could be effective for ALL with no side effects
is required to improve quality of life for patients.
Saccharides play important roles in adhering to cells, transmit-
ting information, and recognizing molecules on the cell mem-
branes through receptors, including lectin.6 For example,
molecular recognition through lactose was found in vivo.7 The
hydration of saccharides with hydrogen bonds provides stability
to the structure of water. The hydration of sugar derivatives was
discussed in relation to the hydration of parent sugars.8 The prepa-
ration and characterization of glycoliposomes have been reported.9
Specific inhibitory effects of three-component liposomes com-
posed of L-a-dimyristoylphosphatidylcholine (DMPC), Tween 20
and sugar surfactants on the growth of tumor cells in vitro have
been reported.10,11Trehalose stabilizes membranes and proteins in cells most
likely by hydrogen bonding. Trehalose liposomes (DMTre) com-
posed of DMPC and trehalose surfactants have been produced by
using the sonication method of a mixture of DMPC and trehalose
surfactants in a buffer solution with no organic solvent.12,13
Remarkable inhibitory effects of DMTre on the growth of human
colon, gastric and hepatocellular carcinoma cells have been
reported.12,13 However, therapeutic effects of DMTre against ALL
were not elucidated. In this study, we investigated therapeutic
effects of DMTre composed of DMPC and trehalose surfactant with-
out any drugs using human ALL (MOLT-4) cells in vitro and xeno-
graft mice model of carcinoma after the inoculation of MOLT-4
cells in vivo.
DMTre were prepared by using sonication (VELVO VS-N300,
300 W, Velvo-clear, Tokyo, Japan) of a mixture containing 30 mol
% L-a-dimyristoylphosphatidylcholine (DMPC, NOF Co., Tokyo,
Japan, purity >99%) and 70 mol % a-D-glycopyranosyl-a-D-glucopy-
ranoside monomyritate (TreC14, Dojindo Ltd, Kumamoto, Japan) in
5% glucose solution at 45 C with 300W, followed by filtration
with a 0.45 lm filter (Scheme 1).
Physical properties of DMTre composed of 30 mol % DMPC and
70 mol % TreC14 were examined. Apparent mean hydrodynamic
diameters (dhy) of DMTre were measured using light scattering
spectrometer (ELS-8000, Otsuka Electronics Co Ltd, Japan) with
He–Ne laser light source (633 nm). The diameter was calculated
by Stokes–Einstein equation (dhy = (jT)/(3pgD)), where j is
Boltzmann constant, T is absolute temperature, g is viscosity and
D is diffusion coefficient. Hydrodynamic diameter (dhy) of DMTre
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Scheme 1. Schematic representation of DMTre.
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which were preserved for a period remaining stable for more than
one month. On the other hand, DMPC liposomes were unstable and
precipitated after 14 days.
We examined the inhibitory effects of DMTre on the growth of
MOLT-4 cells.14 The results are shown in Figure 1. DMTre inhibited(A)
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Figure 1. (A) Inhibitory effects of DMTre on the growth of MOLT-4 cells. (B) Induction
DMTre including NBDPC (DMTre/NBDPC) in the plasma membranes of MOLT-4 cells.the growth of MOLT-4 cells in a dose-dependent manner, though
DMPC liposomes showed no inhibition.
The induction of apoptosis of MOLT-4 cells by DMTre was
examining using flowcytometric analysis. The results are shown
in Figure 1A and B. Apoptotic DNA increased after the treatment
with DMTre as the dose of DMTre increased and reached a high
apoptotic rate (95%), indicating that DMTre induced apoptosis of
MOLT-4 cells.15 We examined the anti-tumor mechanism of DMTre
for MOLT-4 cells. The fusion and accumulation of DMTre including
1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]
dodecanoyl]-sn-glycero-3-phosphocholine (NBDPC) (Avanti Polar
Lipid, LA, USA) as a fluorescence probe toward MOLT-4 cells was
examined using flow cytometer.16 The results are shown in
Figure 1C. An increase in accumulation of DMTre including NBDPC
was observed. In contrast, in the case of DMPC liposomes accumu-
lation was undetected. Furthermore, remarkably high accumula-
tion of DMTre for colon, stomach and liver carcinoma cells have
been clarified.12,13 On the other hand, in the case of DMPC lipo-
somes accumulation was undetected.12,13
To investigate the apoptotic pathways for MOLT-4 cells induced
by DMTre, activation of caspases in MOLT-4 cells after the treat-
ment with DMTre were examined using flowcytometric analysis.17
The results are shown in Figure 2A. High activities of caspase 8, 9,
and 3 were observed, indicating that DMTre induced apoptosis of
MOLT-4 cells through the activation of those caspases. Mitochon-
drial pathway in apoptosis of MOLT-4 cells induced by DMTre
was examined.18 The results are shown in Figure 2B. The mito-
chondrial transmembrane potential of MOLT-4 cells decreased
after the treatment with DMTre, indicating that DMTre induced
apoptosis of MOLT-4 cells through mitochondria pathway.
An increase of cell membrane fluidity has been reported in the
induction of apoptosis for tumor cells.19,20 We evaluated mem-
brane fluidity of MOLT-4 cells using fluorescence polarization(B)
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Figure 2. The apoptotic pathways for MOLT-4 cells induced by DMTre. (A) Activation of caspases for MOLT-4 cells after the treatment with DMTre. (B) Decrease in
mitochondrial transmembrane potential of MOLT-4 cells after the treatment with DMTre.
Figure 3. (A) Membrane fluidity of MOLT-4 cells after the treatment with DMTre. (B) Clustering of lipid rafts in cell membrane for MOLT-4 cells after the treatment with
DMTre.
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decreased after the treatment with DMTre, indicating the increase
in membrane fluidity of MOLT-4 cells. DMTre selectively fused
and accumulated into hepatocarcinoma (Hep-G2 and HuH-7) cells
but not into normal (WI-38) ones, suggesting that membrane of
tumor and normal cells differently uptake DMTre.13 Correlations
between antitumor effects and membrane fluidity of two-compo-
nent liposomes has been reported.22 The clustering of lipid rafts
in plasma membranes of MOLT-4 cells was examined with a mar-
ker Cholera toxin subunit B conjugates Alexa Fluor (CTB), which
binds to the pentasaccharide chains of ganglioside GM1 on the
cellular surfaces.23 The results are shown in Figure 3B. The clus-
tering of lipid rafts in plasma membranes of MOLT-4 cells was
observed after the treatment with DMTre. It has been reported
that the anticancer drugs such as cisplatin and doxorubicin could
induce the clustering of lipid rafts enriched with cholesterol, sph-
ingolipids and ganglioside GM1 in plasma membranes and could
mediate apoptosis toward human carcinoma cells along with the
increase in membrane fluidity.24–26 It has been reported that
hydrolysis of sphingomyelin in ceramide by sphingomyelinases(SMases) following drug treatment may have an impact on bio-
physical plasma membrane properties and structure, and subse-
quently on apoptosis induction.26,27 In addition, remarkably high
membrane fluidity of DMTre compared with that of DMPC has
been clarified.13 It has been reported that the induction of apop-
tosis by hybrid liposomes composed of DMPC and poly-
oxyethylene(n) alkyl ethers could be related to an increase of
membrane fluidity and the formation of lipid rafts in the plasma
membranes of human leukemia HL-60 cells.28 These results sug-
gest that DMTre could induce apoptosis for MOLT-4 cells after
the increase in membrane fluidity and clustering of lipid rafts
when DMTre fused to MOLT-4 cell membranes.
We examined therapeutic effects of DMTre using xenograft
mice models of carcinoma after the inoculation of MOLT-4 cells
in vivo.29 The results are shown in Figure 4AB. It is noteworthy
that a remarkable reduction of tumor weight was obtained in
xenograft mice models treated with DMTre after inoculating
MOLT-4 cells. Specific inhibitory effects of three-component lipo-
somes composed of DMPC, Tween 20 and sugar surfactants on
the growth of tumor cells have been obtained in vitro.10,11 The
Figure 4. Therapeutic effects of DMTre for xenograft mice models of carcinoma after inoculating MOLT-4 cells. (A) Tumor weight of xenograft mouse models of ALL treated
with DMTre. (B) Tumor of xenograft mouse models of ALL with DMTre. (C) Induction of apoptosis for tissue sections in tumor of xenograft mouse models of ALL.
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normal tissue, and the motions of water at the tumor cell sur-
face were more active and disordered state than normal cells.30
The thickness of the fixed aqueous layer of DMTreCn was larger
than that of DMPC.13 Tight bond of trehalose to water molecules
and the phospholipids in bilayer interphase by specific interac-
tions has been reported.31 Therefore, therapeutic effects of
DMTre could be related to hydration of trehalose in tumor cells
of xenograft mice models of ALL. Furthermore, DMTre could
selectively fuse into MOLT-4 cells having high fluidity of mem-
brane in xenograft mice models of ALL, and inhibited the growth
of tumor cells. Next, the induction of apoptosis by DMTre for ALL
was examined in xenograft mice using TUNEL method.32 The
results are shown in Figure 4C. Brown color indicating apoptotic
cells was observed in many tumor cells of xenograft mice after
the treatment with DMTre, although the apoptotic cells were
slightly observed after adding DMPC liposomes. Furthermore,
no cytotoxicity of DMTre on the growth of human normal
fibroblast (WI-38) cells in vitro has been reported.12,13 These
reports suggest that DMTre should not have severe side-effects.
We are currently under investigation about cytotoxicity of
DMTre using normal mice in vivo.
In conclusion, we clearly demonstrated that DMTre showed
inhibitory effects on the growth of MOLT-4 cells along with
apoptosis in vitro and therapeutic effects for xenograft mice
model of carcinoma in vivo. The noteworthy aspects are as fol-
lows. (a) DMTre inhibited the growth of MOLT-4 cells in a
dose-dependent manner due to apoptosis. (b) The activation of
caspase-3, -8, and 9 was obtained for MOLT-4 cells after the
treatment with DMTre. (c) The clustering of lipid rafts in plasma
membranes of MOLT-4 cells was observed after the treatment
with DMTre. (d) Therapeutic effects of DMTre were obtained
for xenograft mice model of carcinoma along with apoptosis
in vivo. It is noteworthy that remarkable high inhibitory effects
of DMTre without drug against ALL along with apoptosis were
obtained for the first time.Acknowledgments
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